Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 7/20 | 0.50 |
| ▸ | FNTB | P49356 | 7/20 | 0.50 |
| ▸ | SMARCA2 | P51531 | 1/20 | 0.39 |
| ▸ | SMARCA4 | P51532 | 1/20 | 0.39 |
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | BACE1 | P56817 | 1/20 | 0.38 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.38 |
| ▸ | ERN1 | O75460 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | CASR | P41180 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6871215 | 0.90 | FNTA (0.51) | FNTAFNTBSMARCA2SMARCA4BRD9 | |
| SCHEMBL6862062 | 0.84 | FNTA (0.43) | FNTAFNTBSMARCA2SMARCA4BRD9 | |
| SCHEMBL8473920 | 0.82 | FNTA (0.50) | FNTAFNTBCYP3A4CNR1 | |
| SCHEMBL6869864 | 0.76 | FNTA (0.49) | FNTAFNTBCYP3A4HSD17B10CNR1 | |
| SCHEMBL4280884 | 0.76 | FNTA (0.78) | FNTAFNTBCYP3A4 | |
| Hydrochloric Acid SCHEMBL5737634 | 0.75 | FNTA (0.77) | FNTAFNTBCYP3A4 | |
| Water SCHEMBL7172972 | 0.75 | FNTA (0.77) | FNTAFNTBCYP3A4 | |
| Hydrochloric Acid SCHEMBL1683542 | 0.74 | FNTA (0.76) | FNTAFNTBCYP3A4 | |
| SCHEMBL27251471 | 0.72 | FNTA (0.66) | FNTAFNTBCYP3A4HSD17B10CNR1 | |
| SCHEMBL14588476 | 0.72 | FNTA (0.64) | FNTAFNTBCYP3A4HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1106610-B1 | Farnesyl transferase inhibiting 2-quinolone derivatives | JANSSEN PHARMACEUTICA NV (BE) | 2004-06-16 | — | — | EP | disclosed |
| EP-1019395-B1 | FARNESYL TRANSFERASE INHIBITING 2-QUINOLONE DERIVATIVES | JANSSEN PHARMACEUTICA NV (BE) | 2002-01-30 | — | — | EP | disclosed |
| EP-1106610-A1 | Farnesyl transferase inhibiting 2-quinolone derivatives | Janssen Pharmaceutica N.V. (BE) | 2001-06-13 | — | — | EP | disclosed |
| EP-1019395-A1 | FARNESYL TRANSFERASE INHIBITING 2-QUINOLONE DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 2000-07-19 | — | — | EP | disclosed |
| US-5968952-A | ANTITUMOR AGENTS | JANSSEN PHARMACEUTICA, N.V. (BE) | 1999-10-19 | — | — | US | disclosed |
| WO-1997016443-A1 | FARNESYL TRANSFERASE INHIBITING 2-QUINOLONE DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 1997-05-09 | — | — | WO | disclosed |